
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Sam 68 CRISPR/Cas9 KO Plasmid (m) | sc-422795 | 20 µg | $397.00 |
Khdrbs1 encodes the RNA-binding protein Sam 68 (KHDRBS1), a STAR family regulator of post-transcriptional gene expression that couples signal transduction to RNA metabolism. Sam 68 binds specific RNA elements to control alternative splicing, mRNA export, stability, and translation, and it participates in dynamic ribonucleoprotein complexes including stress granule–associated pathways. Through phosphorylation-dependent interactions with Src-family kinases and other signaling nodes, Sam 68 influences cell-cycle progression, apoptosis, and differentiation programs. Dysregulation of KHDRBS1/Sam 68–mediated splicing and RNA processing has been linked to oncogenic signaling, neurodevelopmental phenotypes, and immune-related transcriptional states, supporting its broad utility in mechanistic studies.
Sam 68 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Khdrbs1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Khdrbs1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Khdrbs1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Sam 68 protein expression.
This CRISPR knockout system enables efficient generation of Khdrbs1-deficient cell models for investigation of Sam 68 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.